At the time of writing, Amphastar Pharmaceuticals Inc [AMPH] stock is trading at $25.53, up 4.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMPH shares have gain 2.99% over the last week, with a monthly amount glided 5.54%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on May 12, 2025, when JP Morgan downgraded its rating to a Neutral but kept the price target unchanged to $30 for it. Previously, Piper Sandler downgraded its rating to Neutral on February 04, 2025, and dropped its price target to $36. On November 22, 2024, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $55 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $60 on March 05, 2024. BofA Securities initiated its recommendation with a Neutral and recommended $63 as its price target on November 17, 2023.
For the past year, the stock price of Amphastar Pharmaceuticals Inc fluctuated between $22.64 and $53.96. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $25.53 at the most recent close of the market. An investor can expect a potential return of 25.34% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
According to Amphastar Pharmaceuticals Inc [NASDAQ:AMPH], the company’s sales were 730.66M for trailing twelve months, which represents an -0.76% plunge. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.19 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.99 points at the first support level, and at 24.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.90, and for the 2nd resistance point, it is at 26.26.
Ratios To Look Out For
It is important to note that Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] has a current ratio of 2.95. Also, the Quick Ratio is 2.02, while the Cash Ratio stands at 0.92. Considering the valuation of this stock, the price to sales ratio is 1.65, the price to book ratio is 1.62 and price to earnings (TTM) ratio is 9.27.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on May 01 ’25 when 500.0 shares were sold. Director, Petersen Floyd F. completed a deal on May 01 ’25 to buy 500.0 shares. Meanwhile, Director Petersen Floyd F. sold 500.0 shares on Apr 01 ’25.
